GEN vs PSTV · P/E 17, rev $5.00B vs P/E 0.2, rev $5.8M
Gen Digital Inc. (GEN) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the GEN and PSTV stock pages for the full models.
Not investment advice.